Boris Peaker's Stock Ratings

TD Cowen Analyst

Boris Peaker is an analyst at TD Cowen. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 02/22/2025

Overall Average Return

5.39%

Smart Score

45%

Overall Average Return Percentile

46th

Number of Ratings

32
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

This American Express Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Assessing Lantheus Holdings: Insights From 4 Financial Analysts
Deep Dive Into Lantheus Holdings Stock: Analyst Perspectives (4 Ratings)
Analysts See Recent Data from Celldex Therapeutics, Inc. (CLDX) and Ariad Pharmaceuticals, Inc. (ARIA) Through Rose Colored Glasses
Analysts Weigh In On Volatile Biotech Stocks: Illumina, Inc. (ILMN), Heron Therapeutics Inc (HRTX)
Celator Pharma Conference Call to Discuss Phase 3 Trial Results for VYXEOS: Full Transcript
Healthcare Analysts Chime In on Celldex Therapeutics, Inc. (CLDX) and Mast Therapeutics Inc (MSTX) Following Clinical Updates
Analysts Weigh In on Two Small Biotech Stocks: Idera Pharmaceuticals Inc (IDRA), Sequenom, Inc. (SQNM)
Analysts Bullish On Heron Therapeutics Inc (HRTX) Following New Data
Why Cowen & Co Likes Celldex Therapeutics Following Its FDA 'Breakthrough'
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved